Add BrightSurf on Google Email

ADHD medications and work disability and mental health outcomes

03.20.24 | JAMA Network
Apple Watch Series 11 (GPS, 46mm)

Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.

About The Study: In this Swedish nationwide cohort study of 221,000 individuals with attention-deficit/hyperactivity disorder (ADHD), the use of ADHD medication was associated with fewer hospitalizations for both psychiatric and non-psychiatric morbidity and lower suicidal behavior.

Authors: Heidi Taipale, Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.2859)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.2859?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032024

JAMA Network Open

Keywords

Article Information

Contact Information

Jim Michalski
JAMA Network
Jim.Michalski@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2024, March 20). ADHD medications and work disability and mental health outcomes. Brightsurf News. https://www.brightsurf.com/news/12DXVER1/adhd-medications-and-work-disability-and-mental-health-outcomes.html
MLA:
"ADHD medications and work disability and mental health outcomes." Brightsurf News, Mar. 20 2024, https://www.brightsurf.com/news/12DXVER1/adhd-medications-and-work-disability-and-mental-health-outcomes.html.